Marija Kundakovic.

Marija Kundakovic

Professor of biological sciences
Fordham University

Marija Kundakovic is professor of biological sciences at Fordham University. Her lab focuses on hormonal and environmental factors driving sex differences in depression, anxiety and substance use disorders.

She received her Pharm.D. and completed her M.Sc. in experimental pharmacology at the University of Belgrade. She then received her Ph.D. in biochemistry and molecular genetics from the University of Illinois Chicago and completed her postdoctoral training at Columbia University and the Icahn School of Medicine at Mount Sinai. In 2015, she was awarded a NARSAD Young Investigator Award by the Brain & Behavior Research Foundation and established her research laboratory at Fordham University.

Kundakovic has been at the forefront of psychiatric epigenetics research since early in her career. Her lab discovered sex-specific epigenetic regulation in the female brain as a function of the ovarian cycle, providing a new molecular framework to study the female-specific susceptibility to psychiatric disorders. Kundakovic’s research is funded by the U.S. National Institute of Mental Health. She is an elected member of the American College of Neuropsychopharmacology and a council member of the Organization for the Study of Sex Differences.

Explore more from The Transmitter

Collage with a portrait of Caitlin Vander Weele in the foreground.

Frameshift: How Caitlin Vander Weele made science communication her business

Her favorite part of research was talking about it. So she left academia and turned that passion into a successful company.

By Katie Moisse
19 March 2026 | 6 min read
Research image of senescing cells.

Signs of aging vary across brain cells

Senescence presents differently depending on the cell type, toxic trigger and neighboring cells, two new studies find.

By Claudia López Lloreda
18 March 2026 | 4 min read
A computer cursor hovers over distorted data.

Neuroscientists challenge NIH’s proposed human-data access policy

The changes would restrict the sharing of human neuroimaging, transcriptomic and genetic data.

By Claudia López Lloreda
17 March 2026 | 5 min read